227 related articles for article (PubMed ID: 14640996)
21. Reduced serum levels of dehydroepiandrosterone sulphate in adrenal incidentalomas: a marker of adrenocortical tumour.
Flecchia D; Mazza E; Carlini M; Blatto A; Olivieri F; Serra G; Camanni F; Messina M
Clin Endocrinol (Oxf); 1995 Feb; 42(2):129-34. PubMed ID: 7704956
[TBL] [Abstract][Full Text] [Related]
22. Late-night salivary cortisol as a screening test for Cushing's syndrome.
Raff H; Raff JL; Findling JW
J Clin Endocrinol Metab; 1998 Aug; 83(8):2681-6. PubMed ID: 9709931
[TBL] [Abstract][Full Text] [Related]
23. The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing's syndrome.
Refetoff S; Van Cauter E; Fang VS; Laderman C; Graybeal ML; Landau RL
J Clin Endocrinol Metab; 1985 Mar; 60(3):527-35. PubMed ID: 2982900
[TBL] [Abstract][Full Text] [Related]
24. The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome.
Montwill J; Igoe D; McKenna TJ
Steroids; 1994 May; 59(5):296-8. PubMed ID: 8073441
[TBL] [Abstract][Full Text] [Related]
25. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
Ghigo E; Arvat E; Ramunni J; Colao A; Gianotti L; Deghenghi R; Lombardi G; Camanni F
J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
[TBL] [Abstract][Full Text] [Related]
26. Menstrual abnormalities in women with Cushing's disease are correlated with hypercortisolemia rather than raised circulating androgen levels.
Lado-Abeal J; Rodriguez-Arnao J; Newell-Price JD; Perry LA; Grossman AB; Besser GM; Trainer PJ
J Clin Endocrinol Metab; 1998 Sep; 83(9):3083-8. PubMed ID: 9745407
[TBL] [Abstract][Full Text] [Related]
27. Cushing's syndrome: comparison between Cushing's disease and adrenal Cushing's.
Hirsch D; Shimon I; Manisterski Y; Aviran-Barak N; Amitai O; Nadler V; Alboim S; Kopel V; Tsvetov G
Endocrine; 2018 Dec; 62(3):712-720. PubMed ID: 30084101
[TBL] [Abstract][Full Text] [Related]
28. Transsphenoidal resection in Cushing's disease: undetectable serum cortisol as the definition of successful treatment.
Trainer PJ; Lawrie HS; Verhelst J; Howlett TA; Lowe DG; Grossman AB; Savage MO; Afshar F; Besser GM
Clin Endocrinol (Oxf); 1993 Jan; 38(1):73-8. PubMed ID: 8435888
[TBL] [Abstract][Full Text] [Related]
29. Plasma immunoreactive proopiomelanocortin peptides and cortisol in normal dogs and dogs with Addison's disease and Cushing's syndrome: basal concentrations.
Peterson ME; Orth DN; Halmi NS; Zielinski AC; Davis DR; Chavez FT; Drucker WD
Endocrinology; 1986 Aug; 119(2):720-30. PubMed ID: 3015556
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of haemostatic and fibrinolytic markers in patients with Cushing's syndrome and in patients with adrenal incidentaloma.
Ambrosi B; Sartorio A; Pizzocaro A; Passini E; Bottasso B; Federici A
Exp Clin Endocrinol Diabetes; 2000; 108(4):294-8. PubMed ID: 10961361
[TBL] [Abstract][Full Text] [Related]
31. Effect of corticotrophin-releasing hormone on arginine vasopressin and atrial natriuretic factor in patients with Cushing's disease.
Colao A; Pivonello R; Ferone D; Faggiano A; Facciolli G; Di Somma C; Boudouresque F; Oliver C; Lombardi G
Clin Endocrinol (Oxf); 1998 Jul; 49(1):77-84. PubMed ID: 9797850
[TBL] [Abstract][Full Text] [Related]
32. Cortisol and its metabolites in the plasma and urine in Cushing's syndrome with chronic renal failure (CRF), compared to Cushing's syndrome without CRF.
Otokida K; Fujiwara T; Oriso S; Kato M
Nihon Jinzo Gakkai Shi; 1989 Jun; 31(6):651-6. PubMed ID: 2795994
[TBL] [Abstract][Full Text] [Related]
33. Effect of single doses of dexamethasone and adrenocorticotrop hormone on serum bone markers in healthy subjects and in patients with adrenal incidentalomas and Cushing's syndrome.
Majnik J; Szücs N; Patócs A; Tóth M; Balogh K; Varga I; Gláz E; Rácz K
J Endocrinol Invest; 2004 Sep; 27(8):747-53. PubMed ID: 15636428
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis of Cushing's syndrome: re-evaluation of midnight plasma cortisol vs urinary free cortisol and low-dose dexamethasone suppression test in a large patient group.
Görges R; Knappe G; Gerl H; Ventz M; Stahl F
J Endocrinol Invest; 1999 Apr; 22(4):241-9. PubMed ID: 10342356
[TBL] [Abstract][Full Text] [Related]
35. A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome.
Newell-Price J; Trainer P; Perry L; Wass J; Grossman A; Besser M
Clin Endocrinol (Oxf); 1995 Nov; 43(5):545-50. PubMed ID: 8548938
[TBL] [Abstract][Full Text] [Related]
36. Markers of vascular function in hypertension due to Cushing's syndrome.
Zacharieva S; Atanassova I; Nachev E; Orbetzova M; Kirilov G; Kalinov K; Shigarminova R
Horm Metab Res; 2005 Jan; 37(1):36-9. PubMed ID: 15702437
[TBL] [Abstract][Full Text] [Related]
37. A very high dose dexamethasone suppression test for differential diagnosis of Cushing's syndrome.
al-Saadi N; Diederich S; Oelkers W
Clin Endocrinol (Oxf); 1998 Jan; 48(1):45-51. PubMed ID: 9509067
[TBL] [Abstract][Full Text] [Related]
38. Basal and saline-stimulated plasma atrial natriuretic hormone in Cushing's syndrome.
McKnight JA; McCance DR; Roberts G; Sheridan B; Atkinson AB
Acta Endocrinol (Copenh); 1991 Jan; 124(1):7-11. PubMed ID: 1825738
[TBL] [Abstract][Full Text] [Related]
39. Corticosteroids in human blood: IX. Evidence for adrenal secretion of sulfate-conjugated cortisol, 11 beta,17 alpha-dihydroxy-4-pregnene-3,20-dione-21-yl-sulfate.
Kornel L; Patel SK; Ezzeraimi E; Shackleton CH
Steroids; 1995 Dec; 60(12):817-23. PubMed ID: 8650705
[TBL] [Abstract][Full Text] [Related]
40. Plasma concentration of neuropeptide Y in patients with adrenal hypertension.
Tabarin A; Minot AP; Dallochio M; Roger P; Ducassou D
Regul Pept; 1992 Nov; 42(1-2):51-61. PubMed ID: 1475406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
